Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy

ClinicalTrials.gov ID: NCT02221869

Public ClinicalTrials.gov record NCT02221869. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT02221869
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Jazz Pharmaceuticals
Industry
Enrollment
106 participants

Conditions and interventions

Interventions

  • Xyrem Drug

Drug

Eligibility (public fields only)

Age range
7 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2014
Primary completion
Jan 31, 2017
Completion
Jan 24, 2019
Last update posted
Apr 29, 2019

2014 – 2019

United States locations

U.S. sites
17
U.S. states
11
U.S. cities
17
Facility City State ZIP Site status
Miller Children's Hospital - Long Beach Long Beach California 90806
SDS Clinical Trials, Inc. Orange California 92868
Stanford Sleep Medicine Center Redwood City California 94063
Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611
The U-M Sleep Disorders Center Ann Arbor Michigan 48109
Montefiore Medical Center The Bronx New York 10467
Duke Children's Hospital Durham North Carolina 27710
ARSM Research, LLC Huntersville North Carolina 28078
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229
University Hospitals Cleveland Medical Center Cleveland Ohio 44106
Nationwide Children's Hospital Columbus Ohio 43205
SleepMed of SC Columbia South Carolina 29201
Greenville Health System Greenville South Carolina 29615
UT/LeBonheur Neuroscience Institute Memphis Tennessee 38105
Todd Swick, MD, PA Houston Texas 77063
Children's Hospital of The King's Daughters Norfolk Virginia 23507
Seattle Children's Hospital Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02221869, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 29, 2019 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02221869 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →